BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+3.37%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$957M
AUM Growth
+$957M
(+0.11%)
Cap. Flow
+$15.9M
Cap. Flow
% of AUM
1.66%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
140
New
9
Increased
35
Reduced
54
Closed
6
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$24M |
| 2 |
DexCom
DXCM
|
$12.7M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.1M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
$9.58M |
| 5 |
Incyte
INCY
|
$8.07M |
Top Sells
| 1 |
Amgen
AMGN
|
$20.3M |
| 2 |
Gilead Sciences
GILD
|
$15.9M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$10.9M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$8.6M |
| 5 |
AbbVie
ABBV
|
$8.05M |
Sector Composition
| 1 | Healthcare | 95.72% |
| 2 | Financials | 0.41% |
| 3 | Industrials | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $42.2M | 4.41% | 404,265 +71,896 | +22% | +$7.5M |
|
2
Elevance Health
ELV
$71.8B
| $40.8M | 4.26% | 181,243 +10,100 | +6% | +$2.27M |
|
3
Align Technology
ALGN
$10.3B
| $38.6M | 4.03% | 173,596 -19,150 | -10% | -$4.26M |
|
|
4
Intuitive Surgical
ISRG
$170B
| $35.1M | 3.67% | 96,131 +65,754 | +216% | +$24M |
|
5
Illumina
ILMN
$15.8B
| $32.7M | 3.42% | 149,873 -13,652 | -8% | -$2.98M |
|
6
UnitedHealth
UNH
$281B
| $31.5M | 3.29% | 142,910 +6,640 | +5% | +$1.46M |
|
7
Abbott
ABT
$231B
| $30.2M | 3.16% | 530,000 +27,000 | +5% | +$1.54M |
|
|
8
Incyte
INCY
$16.5B
| $21.9M | 2.29% | 231,576 +85,210 | +58% | +$8.07M |
|
|
WBA
9
DELISTED
Walgreens Boots Alliance
WBA
| $21.5M | 2.25% | 296,560 +34,500 | +13% | +$2.51M |
|
10
Edwards Lifesciences
EW
$47.8B
| $21.2M | 2.22% | 188,200 -17,660 | -9% | -$1.99M |
|
11
Jazz Pharmaceuticals
JAZZ
$7.75B
| $20.9M | 2.19% | 155,582 +40,330 | +35% | +$5.43M |
|
12
Hologic
HOLX
$14.9B
| $20.7M | 2.16% | 483,894 +120,793 | +33% | +$5.16M |
|
13
Eli Lilly
LLY
$657B
| $20.4M | 2.13% | 241,262 | – | – |
|
14
Cencora
COR
$56.5B
| $19.4M | 2.02% | 210,941 +12,950 | +7% | +$1.19M |
|
15
Danaher
DHR
$147B
| $18.8M | 1.96% | 202,000 +43,200 | +27% | +$4.01M |
|
16
Medtronic
MDT
$119B
| $17.5M | 1.83% | 217,000 | – | – |
|
17
Boston Scientific
BSX
$156B
| $17.3M | 1.8% | 696,000 | – | – |
|
18
Biogen
BIIB
$19.4B
| $16.7M | 1.74% | 52,300 -6,600 | -11% | -$2.1M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $15.6M | 1.63% | 130,770 +44,770 | +52% | +$5.35M |
|
|
20
DexCom
DXCM
$29.5B
| $15.3M | 1.6% | 266,740 +221,740 | +493% | +$12.7M |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $14.4M | 1.51% | 96,210 +36,410 | +61% | +$5.46M |
|
|
HRC
22
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $14.3M | 1.5% | 169,939 | – | – |
|
|
23
Amgen
AMGN
$155B
| $14.2M | 1.49% | 81,750 -116,895 | -59% | -$20.3M |
|
24
Stryker
SYK
$150B
| $14.1M | 1.48% | 91,300 +7,000 | +8% | +$1.08M |
|
25
Baxter International
BAX
$12.7B
| $14M | 1.46% | 216,000 | – | – |
|